The Race to
Greener Pharma

A greener pharmaceutical industry will not be built through sustainability reports alone. It will be built in the factories where medicines are made. We read the latest ESG reports of eight leading APAC CDMOs to find out what is actually changing on the factory floor.

Cover story by Ayesha Siddiqui · pages 10 to 20

8APAC CDMOs analysed, company by company

80%of pharma's footprint sits in manufacturing

52printed pages, all readable here

16articles, interviews and reports

What is in this issue

Filter by desk, search the full text of every article, or read the contents the way it is printed.

Voices in this issue

The executives, analysts and editors on the record this month. Select any one to open their piece.

Data room: the APAC CDMO sustainability scoreboard

The full comparison table from pages 18 and 19, rebuilt so you can sort it, rank it and read it on a phone.

Rank the eight companies by

FY2025 reporting, except Bushu Pharma (FY2024)

Blank means the company does not disclose that figure in its latest standalone report. Only CDMOs publishing a separate ESG or sustainability report were included in the analysis.

The printed edition, page by page

All 52 pages exactly as they went to press, each one indexed. Use the arrow keys, or select a page to enlarge it.

Page of 52

Keyboard shortcuts

← →: Turn printed pages
J K: Previous and next article in the reading room
T: Cycle paper, dusk and lab reading modes
/: Jump to search
Esc: Close whatever is open
?: Show this list

The Race toGreener Pharma

What is in this issue

Voices in this issue

Data room: the APAC CDMO sustainability scoreboard

The printed edition, page by page

Share this issue

How the sharing links work

The Race to
Greener Pharma